Evidence map›Paper›PMID 35398300›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.

Lee Lee Ho, Santosh Gurung, Imran Mirza, Hemanthi Dassanayake Nicolas, Claudia Steulet, Ashley L Burman, M Carolina Danovaro-Holliday, Samir V Sodha, Katrina Kretsinger

Abstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lee Lee HoWorld Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland. Electronic address: hol@who.int.
Santosh GurungWorld Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
Imran MirzaUnited Nations Children's Fund, 125 Maiden Lane, New York, NY 10038, USA.
Hemanthi Dassanayake NicolasWorld Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
Claudia SteuletWorld Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
Ashley L BurmanWorld Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
M Carolina Danovaro-HollidayWorld Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
Samir V SodhaWorld Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
Katrina KretsingerWorld Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has contributed to the widespread disruption of immunization services, including the postponement of mass vaccination campaigns.

methodsIn May 2020, the World Health Organization and partners started monitoring COVID-19-related disruptions to mass vaccination campaigns against cholera, measles, meningitis A, polio, tetanus-diphtheria, typhoid, and yellow fever through the Immunization Repository Campaign Delay Tracker. The authors reviewed the number and target population of reported preventive and outbreak response vaccination campaigns scheduled, postponed, canceled, and reinstated at 4 time points: May 2020, December 2020, May 2021, and December 2021.

findingsMass vaccination campaigns across all vaccines were disrupted heavily by COVID-19. In May 2020, 105 of 183 (57%) campaigns were postponed or canceled in 57 countries because of COVID-19, with an estimated 796 million postponed or missed vaccine doses. Campaign resumption was observed beginning in July 2020. In December 2021, 77 of 472 (16%) campaigns in 54 countries, mainly in the African Region, were still postponed or canceled because of COVID-19, with about 382 million postponed or missed vaccine doses.

interpretationThere is likely a high risk of vaccine-preventable disease outbreaks across all regions because of an increased number of susceptible persons resulting from the large-scale mass vaccination campaign postponement caused by COVID-19.

Indexed as

COVID-19Vaccine-Preventable DiseasesVaccinesHumansImmunization ProgramsPandemicsSARS-CoV-2VaccinationVaccinescampaignCOVIDglobalSARS-CoV-2 pandemicvaccinationvaccine-preventable diseases

Identifiers

PMID35398300
PMCPMC8985404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.